RE: Whilst I don't like TW16 Jan 2023 11:28
Similar to me AOTG6, although only sold 1/4 of my holding in the .90's and a smidgen over 1. The other 3/4's were dumped on the bell last Tuesday.
Not reporting the CLN's at the time of issue and then reading about it in the AR changed me from a LTH, to a STH and made me angry. Surely investors should have been notified at the time they were taken out, as this changes the financial situation of the company, so shareholders were buying blind of the Wonga interest rate CLN and the other to Koenig(same MD as Orca) with a huge number of Warrants attached. Why did they owe £2m in shares to Orca as well? Could never find out why; maybe the Koenig one paid that off, seeing as companies seem related.
But we don't know what else has been taken out since the AR, or even repaid/settled. They could be hiding more, we just don't know and trust on them revealing information had been lost by me.
I also feel investors were mis-led, as the wording of the Kili scoping study RNs on the 21st Dec didn't have the word "conditional" in it, which had been in the 29th Nov RNS. Just had "With funding secured from OCIM and Philoro". That made me think the conditions had been met, but now we know from the Stockbox interview was that the extra conditions were raised on the 16th. So surely the RNS 5 days later should have kept the word conditional in it?
Then the shares owed, but not listed yet in the AR(Mayflower, Orca, Mgmt incentives) and the RNS' dated 3rd and 12th August and that's without taking into account the 2 CLN's. Are they allowed to have shares owed which haven't been approved in a prospectus? I guess they can, but would be interesting to know.
Won't post again here, so I'd like to wish all shareholders the best and hope for them that it is me that has made a bad decision, having taken the hit here. GLA and more importantly good health!